drugset / Trial / NCT00044473

A Study of the Effectiness and Safety of Levofloxacin in Treating Children With a Rapid and Severe Onset of Infection and Inflammation of the Middle Ear That is Difficult to Treat

NCT00044473

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to assess the rate of elimination of bacteria by levofloxacin in middle ear fluid of children with a rapid and severe onset of infection and inflammation of the middle ear who are at high risk for infections that are difficult to treat.

Timeline

Start
2002-11
Primary completion
Completion
2003-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Levofloxacin Small molecule 10 mg/kg Oral

Indications